Home
About Us
Products
Endoscopic optical components
Endoscopic products
Endoscope parts
Endoscope repair
Blog
Company News
Industry Trends
Service
Contact Us
Language
中文版
English
العربية
Deutsch
Español
Русский
Technical knowledge
Latest News
Future Development Direction
28 Nov,2025
Combining industry technology breakthroughs in 2025 with clinical needs-oriented approaches, medical endoscopes will undergo profound evolution in the fields of intelligence and miniaturization, moving toward greater precision, enhanced flexibility, and adaptability to multiple scenarios. At the same time, this trend will also give rise to innovative forms that integrate with multiple technologies. The following are specific development directions: Intelligent Direction
Policy
In addition to the previously effective policies, the new regulations issued by the National Medical Products Administration (NMPA) concerning high-end medical devices provide stronger support for innovation and development in the medical endoscopy industry. The key contents are as follows, according to the NMPA:
The impact of the policy on businesses and users
Enterprises: Policies provide a solid backing for corporate innovation and development. The special review process for innovative medical devices has significantly shortened the approval cycle for high-end endoscopes, enabling companies to bring their R&D achievements to market more quickly—for instance, Weitong’s intelligent-focus endoscope has been swiftly approved and launched. Meanwhile, the establishment of standardized technical organizations and the dynamic adjustment of product categories have set clear boundaries for corporate R&D, reducing its randomness and uncertainty. At the same time, centralized procurement and medical insurance policies are driving enterprises toward transformation. Under the DRG/DIP payment reform, medical institutions are increasingly favoring cost-effective equipment, prompting companies to shift from simply selling devices to adopting an integrated model that includes “equipment + consumables + services.” Moreover, preferential procurement policies aimed at grassroots-level facilities are guiding enterprises to develop simplified endoscopic products tailored specifically for primary care settings. Additionally, enhanced post-market surveillance requirements are compelling companies to increase their investments in quality testing and adverse-event traceability, thereby raising compliance costs.
Basic Structure and Working Principle of Rigid Endoscopes
09 Feb,2021
Rigid Endoscopes—Shenyang Shenda Endoscopy Co., Ltd. was founded in the 1980s and is one of the earliest domestic manufacturers and developers of medical rigid endoscopes. After more than 30 years of relentless efforts, its range of endoscopes—including the pioneering curved-hose hysteroscope—and associated products have been widely adopted in clinical diagnostics and minimally invasive surgery.